Microwave synthesis, characterization and antimicrobial study of new pyrazolyl-oxopropyl-quinazolin-4(3H)-one derivatives

Journal of Saudi Chemical Society

Volumn 16, Issue 4, 2012, Pages 387-393

  Raval, Jignesh P ^a   Desai, Krunal G ^b   Desai, Kishor R ^c  

^a Ashok & Rita Patel Institute of Integrated Study and Research in Biotechnology and Allied Sciences   (India)

^b VEER NARMAD SOUTH GUJARAT UNIVERSITY   (India)

^c CG Bhakta Institute of Biotechnology   (India)

Author keywords

Antimicrobial activity; Microwave effect; Pyrazolyl oxopropyl quinazolin 4(3H) one; Pyrazolyl quinazoline; Quinazoline

Indexed keywords

EID: 84866179769     PISSN: 13196103     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jscs.2011.02.003     Document Type: Article

References (22)

1. Alagarsamy V., Muthukumar V., Pavalarani N., Asanthanathan P., Revathi R. Biol. Pharm. Bull. 2003, 26:557-559.
2. Alagarsamy V., Shankar D., Siddiqui M., Murugan A.A., Rajesh R. Arch. Pharm. Chem. Life Sci. 2007, 340:41-46.
3. Alagarsamy V., Rupeshkumar M., Kavitha K., Meena S., Shankar D., Siddiqui A.A., Rajesh R. Eur. J. Med. Chem. 2008, 43:2331-2337.
4. Asproni B., Murineddu G., Pau A., Pinna G.A., Langgård M., Christoffersen C.T., Nielsen J., Kehler J. Bioorg. Med. Chem. 2010, 10.1016/j.bmc.2010.10.038.
5. Desai A.R., Desai K.R. ARKIVOC 2005, XIII:98-108.
6. Desai K.G., Desai K.R. Indian J. Chem. 2007, 46B:1179-1186.
7. Gradwol's Clinical Laboratory Methods and Diagnosis 1970, Vol. II. GCLMD, Mosby, C.V. Company, Germany, p. 1407. 7th ed.
8. Loupy A., Perreux L., Liagre M., Burle K., Moneuse M. Pure Appl. Chem. 2001, 73(1):161-166.
9. Mani Chandrika P., Yakaiah T., Raghu Ram Rao A., Narsaiah B., Chakra Reddy N., Sridhar V., Venkateshwara Rao J. Eur. J. Med. Chem. 2008, 43:846-852.
10. Mishra M., Srivastava S.K., Srivastava S.D. Indian J. Chem. 1997, 33B:826-828.
11. NCCLS, 1997. National Committee for Clinical Laboratory Standards. Approved standard NCCLS document M27-A. (ISBN 1-56238-328-0, ISSN 0273-3099). National Committee for Clinical Laboratory Standards, 940, West Valley Road, Suite 1400, Wayne, Pennsylvania.
12. Patel N.B., Barat G.G. J. Saudi Chem. Soc. 2010, 14:157-164.
13. Rather B.A., Raj T., Reddy A., Paul M., Ishar S., Sivakumar S., Paneerselvam P. Arch. Pharm. Chem. Life Sci. 2010, 343:108-113.
14. Raval J.P., Desai K.R. Chemija 2009, 20(2):101-108.
15. Raval J.P., Desai K.G., Desai K.R. J. Iran Chem. Soc. 2006, 3(3):233-241.
16. Raval J.P., Desai J.T., Desai C.K., Desai K.R. Arkivoc 2008, xii:233-244.
17. Raval J.P., Patel H.V., Patel P.S., Patel N.H., Desai K.R. Asian J. Res. Chem. 2009, 2(2):171-177.
18. Raval J.P., Patel H.V., Patel P.S., Desai K.R. J. Saudi Chem. Soc. 2010, 14:417-421.
19. Sinha S., Sritastava M. Progress in Drug Research 1994, vol. 43:143-238. Verlag, Birkhäuser.
20. Tyagi R., Goel B., Srivastava V.K., Kumar A. Indian J. Pharm. Sci. 1998, 60:283-286.
21. Varsha J., Pradeep M., Sushil K., Stables J.P. Eur. J. Med. Chem. 2008, 43:135-141.
22. Wiseloge F.W. Survey of antimalarial drugs: 1941-1945. Advances in Heterocyclic Chemistry 1963, vol. 1:304. Academic Press, New York.